Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S7UH
|
|||
| Former ID |
DIB015848
|
|||
| Drug Name |
ALX-0171
|
|||
| Synonyms |
Anti-RSV nanobody (inhaled), Ablynx
Click to Show/Hide
|
|||
| Indication | Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 1 | [1] | |
| Company |
Ablynx NV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01875926) ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.